Today's announcement makes it look as if GRK is now a failure.A company that for years does nothing that produces revenue, but lives off borrowings and new issues, is deadly.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come